The MoCA ‐ Language (MoCA‐L): A brief screening tool for language disorders in neurodegenerative diseases

The MoCA-L, a brief 6-subtests' screening tool has been developed to improve the detection of language impairments associated with cognitive-linguistic disorders such as PPA and other neurodegenerative diseases. In Phase 2, we plan to establish the psychometric qualities of the test, such as test-retest fidelity, inter-rater reliability, internal consistency and convergent validity. Phase 3 will focus on establishing normative data. Future plans also include the development of an interpretation guide as well as the adaptation of the MoCA-L in various languages and cultures. The MoCA-L will ultimately provide healthcare professionals with a simple and rapid screening tool designed specifically to assess language deficits in neurocognitive disorders, thus improving early diagnosis and management of these diseases.